We’re proud to once again rank as one of San Diego Top Workplaces, marking our second consecutive showing on the prestigious list. The selection is the result of a months-long process involving seven key areas, including “organizational health factors that measure how well employees are working together toward a common cause.”
Our CEO Dr. Joe Smith will be among the experts speaking on the topic of clinical validation for digital care delivery at Clinically Validated Digital Therapeutics 2018 in Boston — a fitting topic for Dr. Smith, who has just ushered his health technology startup company through its first large-scale clinical trial.
The announcement of positive results from the Duke Clinical Research Institute (DCRI)’s long-anticipated “Virtual Exercise Rehabilitation In-home Therapy: A Research Study (VERITAS)” has been reverberating throughout the media in recent weeks, making headlines in healthcare, technology and business publications.
“There was little difference in pain management between the group that used VERA and the one that used traditional in-person physical therapy,” writes Kelsey Ketchum for Healthcare Business & Technology. “This could be an opportunity to cut down on pain medications after surgery, which is a positive considering the national opioid crisis.”
Reflexion Health CEO Dr. Joe Smith recently walked Orthopedics This Week through the results and milestones of the VERITAS clinical trial — the soon-to-be published study showing that our VERA virtual PT platform is as safe and effective as traditional therapy for TKR patients, while offering the power to sharply reduce post-acute costs, to boot.
Fierce Healthcare’s Paige Minemyer recently covered the groundbreaking findings from the Duke Clinical Research Institute (DCRI) that Reflexion Health’s Virtual Exercise Rehabilitation Assistant (VERA™) “could significantly reduce postsurgical costs” associated with knee replacement surgery, with “an average cost savings of $2,745 per patient treated.”
Writing for the San Diego Business Journal, Jared Whitlock discusses the “first large, randomized clinical trial comparing virtual physical therapy with conventional, clinic-centric physical therapy,” which revealed that our VERA™ virtual physical therapy model is “as effective as traditional therapy while saving money.”
Xconomy, a media company covering business and technology developments, recently highlighted the news from the Duke Clinical Research Institute (DCRI) announcing “positive results” from the VERITAS study comparing our Virtual Exercise Rehabilitation Assistant (VERA™) physical therapy platform to traditional PT.
On the heels of the VERITAS study announcement that our VERA™ virtual PT platform enables “substantial” reductions in post-acute costs “while being as effective as traditional physical therapy,” Dr. Joe Smith has penned an article for STAT News describing the need for digital healthcare startups to undergo such clinical trials.
Covering the recent, “long-awaited” announcement that the VERITAS study of our Virtual Exercise Rehabilitation (VERA™) has yielded positive results, mHealthIntelligence’s Erik Wicklund writes that these outcomes “are of interest to providers who want to improve post-discharge patient outcomes and reduce rehospitalizations.”